Barnet pharmacies offer new heartburn test for cancer detection

An NHS-funded project is making a new test for oesophageal conditions available through community pharmacies in Barnet. The initiative, known as COMPASS (Community Pharmacy Assessment for Barrett’s Oesophagus and Reflux symptoms), aims to identify conditions that could lead to cancer at an earlier stage. This programme is a collaboration between Cyted Health and the North Central London Cancer Alliance.

How the test works

Read Next in Barnet Press3 min read

Barnet Residents Face Wi-Fi Rage Within 12 Seconds

New research indicates patience for slow internet is minimal, with bedrooms identified as a common dead zone.

The capsule sponge test involves patients swallowing a small capsule attached to a thin thread. Once inside the stomach, the capsule dissolves, releasing a sponge. This sponge collects cells from the oesophagus as it is carefully pulled back up by a healthcare practitioner. The collected cells are then sent for laboratory testing. Individuals will only be referred for an endoscopy if their test results indicate further investigation is necessary.

Persistent heartburn or acid reflux, common symptoms that many people do not report to their GP, can sometimes indicate an underlying oesophageal condition such as Barrett’s Oesophagus, which is a pre-cancerous condition. By offering this diagnostic pathway in pharmacies, the project seeks to make earlier diagnosis more accessible and reduce pressure on GP services.

Who can access the test

Related Borough Coverage3 min read

Burglars jailed for targeting south Asian families in London

Pair used Oyster card data and CCTV to track movements after stealing jewellery and a Rolex worth £7,000.

The COMPASS project is currently underway in Barnet, Haringey, and Islington, with at least 21 pharmacies across these boroughs participating. The initiative is scheduled to continue until June 2027. Individuals aged 45 and over who are experiencing persistent heartburn or acid reflux are encouraged to visit a participating pharmacy to inquire about the test. Outreach teams are also working to reach vulnerable populations, including those experiencing homelessness, who may have higher rates of cancer.

““By identifying individuals who may be purchasing over-the-counter treatments at a pharmacy for symptoms such as persistent heartburn or reflux, we can investigate symptoms earlier, detect potential cancers sooner, and ultimately save lives.””

Dr Clare Stephens, Co-clinical Director, North Central London Cancer Alliance

Dr Clare Stephens, Co-clinical Director at the North Central London Cancer Alliance, stated that the project is focused on improving cancer survival rates through earlier diagnosis. She highlighted the capsule sponge test as a significant advancement for oesophageal cancer detection, describing it as simple, patient-friendly, and convenient for community settings. Richard Hardwick, Medical Director at Cyted Health, added that the pilot programme brings early warning sign detection directly to the community, making it easier for people to seek checks for chronic acid reflux, which can sometimes lead to oesophageal cancer.